Mutant p53 is overexpressed and accumulated in cancer cells, which not only eliminates the activity of wild-type p53 but also tends to acquire oncogenic functions and interfere with p53-independent apoptosis (Sigal and Rotter, 2000). The gene discussed is TP53; the disease is cancer.